Atlas Trials

A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.

Clinical trial NCT00378183 · COMPLETED

Trial details

NCT number
NCT00378183
Sponsor
Janssen, LP
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizoaffective DisorderSchizophrenia
Start date
2001-02-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.